Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Proqr Therapeutics (NQ: PRQR )

3.660 +0.490 (+15.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,326,252
Open 3.310
Bid (Size) 3.690 (2)
Ask (Size) 3.770 (2)
Prev. Close 3.170
Today's Range 3.230 - 3.850
52wk Range 0.5300 - 3.850
Shares Outstanding 71,290,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via Globe NewsWire
ProQR to Present at Upcoming Scientific and Industry Conferences
From ProQR Therapeutics N.V.
Via Globe NewsWire

Performance

YTD
+7.33%
+7.33%
1 Month
+21.19%
+21.19%
3 Month
+125.93%
+125.93%
6 Month
+380.25%
+380.25%
1 Year
+275.31%
+275.31%

More News

Read More
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023
From ProQR Therapeutics N.V.
Via Globe NewsWire
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline
Via Benzinga
This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing
Via Benzinga
Expert Ratings for ProQR Therapeutics
Via Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
Via Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
Via Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
Via InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
Via InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
Via InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
Via Benzinga
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
Via Benzinga
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
From ProQR Therapeutics N.V.
Via Globe NewsWire
Lilly and ProQR to Expand RNA Editing Collaboration
From ProQR Therapeutics N.V.
Via Globe NewsWire
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
From ProQR Therapeutics N.V.
Via Globe NewsWire
ProQR Announces Third Quarter 2022 Operating and Financial Results
From ProQR Therapeutics N.V.
Via Globe NewsWire
ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
From ProQR Therapeutics N.V.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.